(888) 552-6760 SCHEDULE AN APPOINTMENT

Jeffrey S. Yoshida,

M.D.

Urologist

Biography photo
Location
City of Hope Orange County Lennar Foundation Cancer Center
1000 Five Point
Irvine, CA 92618
Academic Appointments
  • Clinical Professor, Division of Urology and Urologic Oncology, Department of Surgery
  • Medical Director, Division of Urologic Surgery, City of Hope Orange County
About Me

Jeffrey S. Yoshida, MD, is a leading expert in robotic and minimally invasive urologic oncology. As medical director of urologic surgery at City of Hope® Orange County, he brings a highly personalized approach to care, recognizing that both patients and their cancers are uniquely individual. His treatment philosophy emphasizes precision, compassion, and customization for every case. 

Dr. Yoshida earned his medical degree from Loma Linda University, followed by a general surgery internship at Harbor-UCLA and a urology residency at Loma Linda. He then completed a fellowship in laparoscopic oncology and robotic surgery at City of Hope, where he made history as the institution’s first fellow trained in robotic surgery. 

He previously served as associate clinical professor at City of Hope and as medical director of urologic oncology at Hoag Family Cancer Institute, where he was honored with an endowed chair for his contributions to the field. His clinical interests focus on the integration of robotic surgery and advanced molecular imaging to improve outcomes and recovery times for patients facing complex urologic cancers. 

Widely recognized for his expertise, Dr. Yoshida continues to advance minimally invasive surgical techniques and has helped shape the evolution of modern urologic oncology. 

When not in the operating room or clinic, Dr. Yoshida enjoys surfing and spending quality time with his family and their dog.

Patient ratings
Star ratings and comments are only available for medical, radiation and gynecologic oncologists. Gynecologic surgical offerings are not included at this time due to a different survey tool required to evaluate these services. CTCA uses a validated Press Ganey® survey, which captures patient experience feedback for the primary oncology services of chemotherapy and radiation therapy at our comprehensive care and research centers. Following industry best practice, star ratings and comments are only published for physicians with a minimum of 30 completed patient surveys.